These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6303606)

  • 21. Polio immunization.
    Tulchinsky TH; Goldblum N
    N Engl J Med; 2001 Jan; 344(1):61-2; author reply 62-3. PubMed ID: 11187114
    [No Abstract]   [Full Text] [Related]  

  • 22. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monovalent neonatal polio immunization--a strategy for the developing world.
    Schoub BD; Johnson S; McAnerney J; Gilbertson L; Klaassen KI; Reinach SG
    J Infect Dis; 1988 Apr; 157(4):836-9. PubMed ID: 2831290
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.
    Gudnadóttir M
    Dev Biol Stand; 1981; 47():257-9. PubMed ID: 7227654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulse and routine immunization against poliomyelitis.
    John TJ
    Indian Pediatr; 1998 Dec; 35(12):1239-40. PubMed ID: 10216706
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined use of live and killed vaccines to control poliomyelitis in tropical areas.
    Melnick JL
    Dev Biol Stand; 1981; 47():265-73. PubMed ID: 7227655
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibody response to live trivaccine against poliomyelitis in adults].
    Koza J; Skocil V; Matyásová I; Bruj J
    Cesk Epidemiol Mikrobiol Imunol; 1984 Jul; 33(4):232-6. PubMed ID: 6091925
    [No Abstract]   [Full Text] [Related]  

  • 29. Neutralizing antibodies against poliovirus serotypes among children in southwest Nigeria.
    Adewumi MO; Donbraye E; Odaibo GN; Bakarey AS; Opaleye OO; Olaleye DO
    J Trop Pediatr; 2006 Apr; 52(2):92-5. PubMed ID: 16014758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent improvements in polio and pertussis vaccination policy in Israel, 2005.
    Rishpon S
    Isr Med Assoc J; 2006 May; 8(5):319-21. PubMed ID: 16805229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Poliomyelitis--why we must continue to vaccinate!].
    Windorfer A; Beyrer K
    MMW Fortschr Med; 2005 Feb; 147(8):36, 38, 40. PubMed ID: 18437859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of poliomyelitis].
    Schär M
    Ther Umsch; 1983 Mar; 40(3):206-8. PubMed ID: 6857558
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comment on the contribution by Pietsch, R., H. Riegel: Implementation of poliomyelitis revaccination].
    Dittmann S; Koch MA; Diedrich S; Maass G; Böthig B
    Gesundheitswesen; 1993 Jul; 55(7):381-3. PubMed ID: 8396469
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antibodies against poliomyelitis in children of Comayagua Valley, Honduras].
    Cáceres LM; Figueroa M; Tróchez H
    Bol Oficina Sanit Panam; 1973 Nov; 75(5):424-9. PubMed ID: 4271453
    [No Abstract]   [Full Text] [Related]  

  • 35. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey.
    Trivello R; Farisano G; Bonello C; Moschen ME; Baldo V; Majori S; Moretti G; Marin V; Piron L; Renzulli G
    Ann Clin Lab Sci; 1994; 24(6):542-7. PubMed ID: 7847782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation and use of inactivated vaccine against acute anterior poliomyelitis in the Netherlands].
    van Wezel AL; van Steenis G; Hannik CA; Kapsenberg JG; Hofman B; Cohen H
    Ned Tijdschr Geneeskd; 1979 Mar; 123(12):466-74. PubMed ID: 424009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.